NIST DNA DIAGNOSTICS DEVELOPMENT FUNDING OF $145 MIL.
This article was originally published in The Gray Sheet
Executive Summary
NIST DNA DIAGNOSTICS DEVELOPMENT FUNDING OF $145 MIL. will be provided over the next five years under the National Institute of Standards and Technology's Advanced Technology Program. The grants, to be matched by industry, will fund projects that pursue "cost-effective methods for sequencing, interpreting, and storing DNA sequences for diagnostic applications ranging from healthcare to agriculture to environmental monitoring," the Department of Commerce's NIST says in background material.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.